A Pooled Analysis of the HGS1006-C1056 (BLISS-52) and HGS1006-C1057 (BLISS-76) Studies

计划入组 1 人 · 首次发布于 2013 年 5 月 21 日

Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76

计划入组 1,016 人 · 首次发布于 2013 年 8 月 2 日

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

计划入组 170 人 · 首次发布于 2020 年 11 月 3 日

Spinal Bliss

LN-040

LN-006

BLISS GVS PHARMA LIMITED

India

Bliss Biopharmaceutical (Hangzhou) Co., Ltd.

China

Iovance Biotherapeutics

United States

Belimumab Shows Superior Outcomes in Pediatric Lupus Nephritis Treatment Study

FDA Approves First Lupus Nephritis Treatment: GSK's Benlysta Autoinjector for Pediatric Patients

Lupus Nephritis Drug Market Transforms with Targeted Therapies as Unmet Medical Needs Drive Innovation